Abstract
Maridomycin, a new macrolide antibiotic, and tetrahydromaridomycin were acylated into their mono, di, and tri acyl derivatives.
These derivatives were compared with the parent antibiotic, maridomycin, for their (i) in vitro antimicrobial activities, (ii) protective effect in mice infected with Staphylococcus aureus (oral administration), (iii) blood levels attained in rats, and (iv) acute toxicity in mice (intraperitoneal administration). All the derivatives showed either the same or less activity in vitro, but 9-acyl, 9, 2′-diacylmaridomycin and 9, 13, 2′-triacetyltetrahydromaridomycin demonstrated improved therapeutic effects together with higher blood levels and low toxicity. 9-Propionylmaridomycin showed the most favorable biological properties.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GRIFFITH R. S. Laboratory and clinical studies with erythromycin propionate. Antibiot Annu. 1958;6:364–374. [PubMed] [Google Scholar]
- Muroi M., Izawa M., Kishi T. Structures of maridomycin 1,3,4,5 and 6 macrolide antibiotics. Experientia. 1972 Feb 15;28(2):129–131. doi: 10.1007/BF01935709. [DOI] [PubMed] [Google Scholar]
- Muroi M., Izawa M., Ono H., Higashide E., Kishi T. Isolation of maridomycins and structure of maridomycin II. Experientia. 1972 Aug 15;28(8):878–880. doi: 10.1007/BF01924916. [DOI] [PubMed] [Google Scholar]
- Ono H., Hasegawa T., Higashide E., Shibata M. Maridomycin, a new macrolide antibiotic. I. Taxonomy and fermentation. J Antibiot (Tokyo) 1973 Apr;26(4):191–198. doi: 10.7164/antibiotics.26.191. [DOI] [PubMed] [Google Scholar]
- STEPHENS V. C., CONINE J. W., MURPHY H. W. Esters of erythromycin. IV. Alkyl sulfate salts. J Am Pharm Assoc Am Pharm Assoc. 1959 Nov;48:620–622. [PubMed] [Google Scholar]